Senior Living Shakeout: Leaders After Genesis
This carefully selected group of stocks represents companies positioned to thrive following Genesis HealthCare's bankruptcy. Handpicked by our analysts, these healthcare providers and REITs stand to gain significant market share as the senior care industry undergoes a major transformation.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Ensign Group Inc
ENSG
Current price
$167.02
As a financially robust operator of skilled nursing and senior living facilities, The Ensign Group is a direct competitor positioned to acquire Genesi...
As a financially robust operator of skilled nursing and senior living facilities, The Ensign Group is a direct competitor positioned to acquire Genesis assets and gain market share.
National HealthCare Corporation
NHC
Current price
$109.33
National HealthCare Corporation's strong operational track record in skilled nursing and assisted living makes it a likely candidate to absorb patient...
National HealthCare Corporation's strong operational track record in skilled nursing and assisted living makes it a likely candidate to absorb patients and properties from the Genesis bankruptcy.
Brookdale Senior Living Inc.
BKD
Current price
$7.19
As one of the largest senior living operators, Brookdale could benefit from industry consolidation by acquiring facilities from the distressed Genesis...
As one of the largest senior living operators, Brookdale could benefit from industry consolidation by acquiring facilities from the distressed Genesis portfolio at favorable prices.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Genesis HealthCare's bankruptcy reveals deep vulnerabilities in traditional nursing homes, creating opportunities for stronger operators. Companies with healthy balance sheets, specialized services, and innovative care models are now positioned to absorb market share and redefine senior living standards in this industry-wide shakeout.
What You Need to Know
This theme represents a tactical opportunity following a clear market disruption. The stocks span facility operators, healthcare REITs, home health providers, and specialized service companies—all poised to benefit from industry consolidation. These companies have financial stability while many competitors face operational pressures.
Why These Stocks
Each company was selected for its strong position to capitalize on Genesis HealthCare's downfall. Our analysts focused on businesses with robust balance sheets, diversified care models, and the operational capacity to acquire distressed assets or capture displaced patients in this rapidly evolving healthcare sector.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+7.10%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 7.1% over the next year.
Stocks Rated Buy by Analysts
11 of 15 assets in this group are rated Buy by professional analysts.
Group Growth vs Bank interest
This group averaged a 11.2% return last month, beating the typical 4% bank rate.
Why You'll Want to Watch These Stocks
Major Industry Shift Happening Now
Genesis's bankruptcy isn't just company news—it's reshaping the entire senior care landscape. These stocks represent the companies gaining strength while others struggle, giving you access to a clear market transition as it unfolds.
Value Hunting Ground
With distressed assets becoming available, financially strong companies can make acquisitions at bargain prices. This often creates substantial shareholder value as they expand their footprint without overpaying during this market disruption.
Under-the-Radar Opportunity
While headlines focus on Genesis's problems, smart investors are watching who benefits from the fallout. This curated list saves you from having to identify the winners yourself in a complex healthcare subsector undergoing rapid change.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.